BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1225 related articles for article (PubMed ID: 15637473)

  • 1. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.
    Ryeom HK; Kim SH; Kim JY; Kim HJ; Lee JM; Chang YM; Kim YS; Kang DS
    Korean J Radiol; 2004; 5(4):231-9. PubMed ID: 15637473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver function test by gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging with consideration of intrahepatic regional differences.
    Okubo H; Mogami M; Ozaki Y; Igusa Y; Aoyama T; Amano M; Kokubu S; Miyazaki A; Watanabe S
    Hepatogastroenterology; 2013 Oct; 60(127):1547-51. PubMed ID: 23933786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative evaluation of liver function with T1 relaxation time index on Gd-EOB-DTPA-enhanced MRI: comparison with signal intensity-based indices.
    Kamimura K; Fukukura Y; Yoneyama T; Takumi K; Tateyama A; Umanodan A; Shindo T; Kumagae Y; Ueno S; Koriyama C; Nakajo M
    J Magn Reson Imaging; 2014 Oct; 40(4):884-9. PubMed ID: 24677659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hepatocyte phase of Gd-EOB-DTPA-enhanced MRI in the evaluation of hepatic fibrosis and early liver cirrhosis in a rat model: an experimental study.
    Ma C; Liu A; Wang Y; Geng X; Hao L; Song Q; Sun B; Wang H; Zhao G
    Life Sci; 2014 Jul; 108(2):104-8. PubMed ID: 24881519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Liver Function by T1 Maps on Gd-EOB-DTPA-Enhanced MRI for up to 50 Min in Rat Models of Liver Fibrosis: A Longer Hepatobiliary Time Period may Help.
    Xu J; Wang X; Jin ZY; Wang Q; You Y; Wang ST; Qian TY; Xue HD
    Chin Med Sci J; 2021 Jun; 36(2):110-119. PubMed ID: 34231459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of liver function in thioacetamide-induced rat acute liver injury using an empirical mathematical model and dynamic contrast-enhanced MRI with Gd-EOB-DTPA.
    Saito S; Moriyama Y; Kobayashi S; Ogihara R; Koto D; Kitamura A; Matsushita T; Nishiura M; Murase K
    J Magn Reson Imaging; 2012 Dec; 36(6):1483-9. PubMed ID: 22711439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring hepatic functional reserve using T1 mapping of Gd-EOB-DTPA enhanced 3T MR imaging: A preliminary study comparing with
    Nakagawa M; Namimoto T; Shimizu K; Morita K; Sakamoto F; Oda S; Nakaura T; Utsunomiya D; Shiraishi S; Yamashita Y
    Eur J Radiol; 2017 Jul; 92():116-123. PubMed ID: 28624009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume-assisted estimation of liver function based on Gd-EOB-DTPA-enhanced MR relaxometry.
    Haimerl M; Schlabeck M; Verloh N; Zeman F; Fellner C; Nickel D; Barreiros AP; Loss M; Stroszczynski C; Wiggermann P
    Eur Radiol; 2016 Apr; 26(4):1125-33. PubMed ID: 26186960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gd-EOB-DTPA-enhanced MRI T1 mapping for assessment of liver function in rabbit fibrosis model: comparison of hepatobiliary phase images obtained at 10 and 20 min.
    Zhou ZP; Long LL; Huang LJ; Yang TF; Huang ZK
    Radiol Med; 2017 Apr; 122(4):239-247. PubMed ID: 28070844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-EOB-DTPA for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in Rats.
    Zhang W; Kong X; Wang ZJ; Luo S; Huang W; Zhang LJ
    PLoS One; 2015; 10(6):e0129621. PubMed ID: 26076199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging.
    Pan S; Wang XQ; Guo QY
    World J Gastroenterol; 2018 May; 24(18):2024-2035. PubMed ID: 29760545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
    Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
    Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice.
    Yamada T; Obata A; Kashiwagi Y; Rokugawa T; Matsushima S; Hamada T; Watabe H; Abe K
    Magn Reson Imaging; 2016 Jul; 34(6):724-729. PubMed ID: 26979540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-treatment estimation of future remnant liver function using gadoxetic acid MRI in patients with HCC.
    Yoon JH; Choi JI; Jeong YY; Schenk A; Chen L; Laue H; Kim SY; Lee JM
    J Hepatol; 2016 Dec; 65(6):1155-1162. PubMed ID: 27476767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
    Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J
    Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four indices on Gd-EOB-DTPA-enhanced MRI can estimate liver functional reserve compared to ICG-R15: A systematic review and meta-analysis.
    Ai X; Wang H; Yang Y; Feng Y; Xie X; Zhao X; Li J; Yao P; Zhu Q
    Clin Imaging; 2023 Oct; 102():1-8. PubMed ID: 37437466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function.
    Yoneyama T; Fukukura Y; Kamimura K; Takumi K; Umanodan A; Ueno S; Nakajo M
    Eur Radiol; 2014 Apr; 24(4):857-65. PubMed ID: 24356768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers.
    Brismar TB; Dahlstrom N; Edsborg N; Persson A; Smedby O; Albiin N
    Acta Radiol; 2009 Sep; 50(7):709-15. PubMed ID: 19701821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of Gd-EOB-DTPA as an imaging biomarker for liver injury estimation after radiation therapy.
    Sun XL; Jiang X; Kuang Y; Xing L; Bu LY; Yuan SH; Yu JM; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):354-359. PubMed ID: 31221569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA.
    Saito S; Obata A; Kashiwagi Y; Abe K; Murase K
    Invest Radiol; 2013 Jul; 48(7):548-53. PubMed ID: 23442774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.